Midodrine Tillomed Laboratories (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Tillomed Laboratories, is an Alpha-1 adrenergic agonist presented as a tablet for oral use. It is used to raise blood pressure in patients with orthostatic hypotension and related conditions.

GNH USA supplies Midodrine Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine acts on the peripheral vascular system to treat low‑blood‑pressure disorders. - Orthostatic hypotension: increases standing systolic pressure and reduces dizziness or fainting. - Neurogenic hypotension: improves vascular tone in autonomic failure. - Chronic hypotension: supports overall blood‑pressure stability in patients with persistent low readings.

Midodrine may cause a range of adverse reactions, most of which are dose‑related.

Common Side Effects: - Piloerection (goose‑flesh skin) - Pruritus (itching) - Urinary retention - Supine hypertension - Headache - Paresthesia (tingling)

Serious or Rare Side Effects: - Severe hypertension (especially when lying down) - Myocardial infarction - Pulmonary edema - Bradycardia - Anaphylactic reactions - Skin necrosis at injection sites (if applicable)

Before prescribing Midodrine, clinicians should consider several safety measures. - Monitor blood pressure: check supine and standing readings regularly. - Avoid use in severe cardiac disease: risk of excessive vasoconstriction. - Caution in renal impairment: adjust monitoring as clearance may be affected. - Do not combine with other vasopressors without supervision. - Pregnancy: safety unknown; weigh benefits against potential risks. - Store at below 25°C: keep in the original pack, protect from moisture.

Midodrine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other alpha‑agonists: additive pressor effect may cause severe hypertension. - Tricyclic antidepressants: can amplify blood‑pressure response.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect when discontinued. - Beta‑blockers: may mask compensatory tachycardia. - Anticholinergics: may worsen urinary retention. - Calcium channel blockers: possible additive vascular effects.